Pfizer 500 (Bosulif 500 mg)
Generic Name: bosutinib
Pill imprint Pfizer 500 has been identified as Bosulif 500 mg.
Bosulif is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Bosulif (bosutinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review – Add your own review/rating
- Drug class: BCR-ABL tyrosine kinase inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.